Position in LLY
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$2,409,654
+$565,516 QoQ
Shares Held
2,009
+0.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.94%
of 13F equity value
Holder Rank
#2,328
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Atlas Brown,Inc. holds $23,716,828 across 9 Drug Manufacturers - General names. LLY ranks #3 (10.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
32,094 | $8,150,913 | |
| 2 | ABBV |
AbbVie Inc.
|
30,004 | $7,550,205 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
2,009 | $2,409,654 | |
| 4 | MRK |
Merck & Co., Inc.
|
16,181 | $2,079,258 | |
| 5 | PFE |
Pfizer Inc
|
80,876 | $1,947,493 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
13,373 | $770,551 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,508 | $443,200 | |
| 8 | GSK |
GSK plc
|
4,053 | $212,458 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,409,654 | 2,009 | Shares | Defined | 2026-07-09 | |
| 2026-03-31 | $1,844,138 | 2,005 | Shares | Defined | 2026-04-17 | |
| 2025-12-31 | $2,122,493 | 1,975 | Shares | Defined | 2026-01-09 | |
| 2025-09-30 | $1,502,347 | 1,969 | Shares | Defined | 2025-10-17 | |
| 2025-06-30 | $1,510,729 | 1,938 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $1,584,095 | 1,918 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $1,469,116 | 1,903 | Shares | Sole | 2025-01-10 | |
| 2024-09-30 | $1,681,514 | 1,898 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $1,789,030 | 1,976 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $1,502,240 | 1,931 | Shares | Sole | 2024-04-08 | |
| 2023-12-31 | $1,025,939 | 1,760 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $945,348 | 1,760 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $825,404 | 1,760 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $604,419 | 1,760 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $848,748 | 2,320 | Shares | Sole | 2023-01-05 | |
| 2022-09-30 | $839,093 | 2,595 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $833,271 | 2,570 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $735,970 | 2,570 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $709,885 | 2,570 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $593,798 | 2,570 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $589,866 | 2,570 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $480,127 | 2,570 | Shares | Sole | 2021-04-13 | |
| 2020-12-31 | $433,918 | 2,570 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $380,411 | 2,570 | Shares | Sole | 2020-10-15 | |
| 2020-06-30 | $421,942 | 2,570 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $356,510 | 2,570 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||